Skip to main content
Shanghai Kindly Enterprise Development Group Co.,Ltd. logo

Shanghai Kindly Enterprise Development Group Co.,Ltd. — Investor Relations & Filings

Ticker · 603987 ISIN · CNE100003076 LEI · 3003003G07QZESUB1P38 Shanghai Stock Exchange Manufacturing
Filings indexed 1,380 across all filing types
Latest filing 2024-04-19 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603987

About Shanghai Kindly Enterprise Development Group Co.,Ltd.

https://www.kindly-group.com/

Shanghai Kindly Enterprise Development Group Co., Ltd. specializes in the research, development, and manufacturing of medical puncture instruments and related consumables. The company's product portfolio includes a wide range of hypodermic needles, syringes, infusion sets, and blood collection devices. KDL also produces specialized medical components such as insulin needles, dental needles, and aesthetic medical instruments. With a focus on precision engineering and high-quality standards, the group serves a global market, providing essential medical supplies to healthcare facilities and distributors. The company maintains a comprehensive production chain from raw materials to finished products, ensuring consistency and safety in clinical applications.

Recent filings

Filing Released Lang Actions
上海康德莱企业发展集团股份有限公司内部控制审计报告2023年度
Regulatory Filings
2024-04-19 Chinese
上海康德莱企业发展集团股份有限公司关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in accounting policy by Shanghai Kangdelai Enterprise Development Group Co., Ltd. It details the nature of the accounting policy change, its impact on financial statement items, and includes opinions from the supervisory board and the accounting firm. The document references the application of a new accounting standard issued by the Ministry of Finance and includes retrospective adjustments to financial statement items for 2022 and 2023. It also mentions an audit report attached for the 2023 fiscal year. The document length is 2071 characters, which is relatively short and primarily serves as an announcement of the accounting policy change and related adjustments rather than a full financial report. It does not contain comprehensive financial statements or detailed financial analysis itself. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is an official announcement about accounting policy changes and related audit opinions, but not the full annual report or audit report itself.
2024-04-19 Chinese
上海康德莱企业发展集团股份有限公司关于延长向不特定对象发行可转换公司债券股东大会决议有效期及授权有效期的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from Shanghai Kangdelai Enterprise Development Group Co., Ltd. regarding the extension of the validity period of a shareholders' meeting resolution and authorization related to the issuance of convertible bonds to unspecified investors. It details board and supervisory meetings and resolutions about extending the validity period of prior shareholder approvals. The document is short (1014 characters) and serves as an announcement of a corporate governance action related to financing activities but does not contain financial statements or detailed financial data. It is not a full report, earnings release, or detailed management discussion. The content fits best under Capital/Financing Update (CAP) as it concerns updates on company financing activities and capital structure changes (extension of convertible bond issuance authorization).
2024-04-19 Chinese
上海康德莱企业发展集团股份有限公司2023年年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as "2023 年年度股东大会会议资料" which translates to "2023 Annual General Meeting (AGM) Meeting Materials". It contains detailed agenda items for the 2023 Annual General Meeting, including reports from the board of directors, supervisory board, independent directors, financial reports, profit distribution proposals, and other shareholder meeting proposals. The content is clearly the materials prepared and shared for the AGM, including meeting agenda, voting instructions, and detailed reports to be reviewed during the meeting. There is no indication that this is the full annual report (10-K) or a financial statement filing, but rather the presentation and documents for the AGM itself. The document length is substantial (15,000 characters), consistent with detailed AGM materials. Therefore, the document fits the category of AGM Information (AGM-R).
2024-04-19 Chinese
上海康德莱企业发展集团股份有限公司关于2024年度重大固定资产投资计划的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shanghai Kangdelai Enterprise Development Group Co., Ltd. regarding its 2024 major fixed asset investment plan. It details the planned investment amounts, project descriptions, funding sources, and risk analysis. The document is relatively short (1376 characters) and focuses on capital expenditure plans rather than financial results or regulatory filings. It does not contain financial statements or quarterly/yearly performance data. The content aligns with updates on company fundraising, financing activities, or capital structure changes, specifically about fixed asset investments. Therefore, the document fits best under the category 'Capital/Financing Update' (CAP).
2024-04-19 Chinese
上海康德莱企业发展集团股份有限公司关于确认2023年度日常性关联交易及预计2024年度日常性关联交易的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the confirmation of 2023 daily related party transactions and the forecast for 2024 daily related party transactions by Shanghai Kangdelai Enterprise Development Group Co., Ltd. It includes information about the board meeting approvals, independent directors' opinions, transaction amounts, related parties, and the impact on the company. The document is a formal announcement of related party transactions, which is a regulatory disclosure but does not contain comprehensive financial statements or a full financial report. It is not an annual report, interim report, earnings release, or audit report. It is a regulatory announcement about related party transactions, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit other specific categories.
2024-04-19 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.